Algernon Pharmaceuticals (XCNQ:AGN) Price-to-Operating-Cash-Flow : (As of Apr. 29, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Algernon Pharmaceuticals Price-to-Operating-Cash-Flow?

As of today (2024-04-29), Algernon Pharmaceuticals's share price is C$0.13. Algernon Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Nov. 2023 was C$-0.15. Hence, Algernon Pharmaceuticals's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Algernon Pharmaceuticals's Price-to-Operating-Cash-Flow or its related term are showing as below:

XCNQ:AGN's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.7
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Algernon Pharmaceuticals's Cash Flow from Operations per share for the three months ended in Nov. 2023 was C$-0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Nov. 2023 was C$-0.15.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 52.50% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 19.20% per year.

During the past 9 years, Algernon Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 52.50% per year. The lowest was -31.80% per year. And the median was 20.50% per year.

Algernon Pharmaceuticals Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Algernon Pharmaceuticals's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Algernon Pharmaceuticals Price-to-Operating-Cash-Flow Chart

Algernon Pharmaceuticals Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Algernon Pharmaceuticals Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Algernon Pharmaceuticals's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Algernon Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Algernon Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Algernon Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Algernon Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Algernon Pharmaceuticals Price-to-Operating-Cash-Flow Calculation

Algernon Pharmaceuticals's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.13	/	-0.151
	=

Algernon Pharmaceuticals's Share Price of today is C$0.13.
Algernon Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.15.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Algernon Pharmaceuticals Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Algernon Pharmaceuticals's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Algernon Pharmaceuticals (XCNQ:AGN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Algernon Pharmaceuticals Inc (XCNQ:AGN) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

AGNPF:USA AGW0:Germany

Address

601 West Broadway, Suite 400, Vancouver, BC, CAN, V5Z 4C2

Website

https://www.algernonpharmaceuticals.com

Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis and chronic cough. The company's business model is capital efficient and strives to deliver maximum shareholder value. Algernon's approach to drug discovery is based on the concept of drug repurposing. It operates in two reportable segments: the development of repurposed therapeutic drugs in Canada, and the facilitation of the Company's drug candidates into off-label phase II clinical trials (humans) in Australia.

Algernon Pharmaceuticals (XCNQ:AGN) Headlines

No Headlines